Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Business

New Report Available: Gilead Sciences, Inc. - SWOT, Strategy and Corporate Finance Report


Print article Print article
2013-12-08 04:02:32 - Recently published research from MarketLine, "Gilead Sciences, Inc. - SWOT, Strategy and Corporate Finance Report", is now available at Fast Market Research

Gilead Sciences, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360deg view of the company.

Features:

* Detailed information on Gilead Sciences, Inc. required for business and competitor intelligence needs
* A study of the major internal and external factors affecting Gilead Sciences, Inc. in the form of a SWOT analysis
* An in-depth view of the business model of Gilead Sciences, Inc. including a breakdown and examination of key business segments
* Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios

for Gilead Sciences, Inc.
* Intelligence on Gilead Sciences, Inc.nv's mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
* News about Gilead Sciences, Inc., such as business expansion, restructuring, and contract wins
* Large number of easy-to-grasp charts and graphs that present important data and key trends

Full Report Details at
- www.fastmr.com/prod/736893_gilead_sciences_inc_swot_strategy_and ..

Highlights:

Gilead Sciences (Gilead or 'the company') is a biopharmaceutical company engaged in developing and marketing therapies for HIV/AIDS, liver disease and serious cardiovascular and respiratory conditions. The company operates in North America, Europe and Australia. It is headquartered in Foster City, California, and employed about 5,000 people as of January 31, 2013. The company recorded revenues of $9,702.5 million during the financial year ended December 2012 (FY2012), an increase of 15.7% over FY2011. The operating profit of the company was $4,010.2 million in FY2012, an increase of 5.8% over FY2011. The net profit was $2,591.6 million in FY2012, a decrease of 7.6% over FY2011.

Reasons to Purchase:

* Gain understanding of Gilead Sciences, Inc. and the factors that influence its strategies
* Track strategic initiatives of the company and latest corporate news and actions
* Assess Gilead Sciences, Inc. as a prospective partner, vendor or supplier
* Support sales activities by understanding your customers' businesses better
* Stay up to date on Gilead Sciences, Inc.'s business structure, strategy and prospects

Companies Mentioned in this Report: Gilead Sciences, Inc.

Partial Table of Contents:

Company Snapshot
Gilead Sciences, Inc.: Company Overview
Gilead Sciences, Inc.: Overview and Key Facts
Gilead Sciences, Inc.: Overview
Gilead Sciences, Inc.: Key Facts
Gilead Sciences, Inc.: Key Employees
Gilead Sciences, Inc.: Key Employee Biographies
Gilead Sciences, Inc.: Major Products and Services
Gilead Sciences, Inc.: Company History
Gilead Sciences, Inc.: Management Statement
Gilead Sciences, Inc.: Locations and Subsidiaries
Gilead Sciences, Inc.: Key Competitors
Gilead Sciences, Inc.: Company Analysis
Gilead Sciences, Inc.: Business Description
Gilead Sciences, Inc.: SWOT Analysis
Gilead Sciences, Inc.: SWOT Overview
Gilead Sciences, Inc.: Strengths
Gilead Sciences, Inc.: Weaknesses
Gilead Sciences, Inc.: Opportunities
Gilead Sciences, Inc.: Threats
Gilead Sciences, Inc.: Corporate Financial Deals Activity
Gilead Sciences, Inc.: Financial Deals Overview
Gilead Sciences, Inc.: Targets and Partners
Gilead Sciences, Inc.: Top Deals 2009 - 2013YTD*
Gilead Sciences, Inc.: Advisors
Gilead Sciences, Inc.: Top Legal Advisors
Gilead Sciences, Inc.: Top Financial Advisors
Gilead Sciences, Inc.: Mergers and Acquisitions
Gilead Sciences, Inc.: Capital Raising
Gilead Sciences, Inc.: Partnership
Gilead Sciences, Inc.: Private Equity and Ownership
Gilead Sciences, Inc.: Recent Developments
Gilead Sciences, Inc.: News and Events Summary
Gilead Sciences, Inc.: Contracts
Gilead Sciences, Inc.: Corporate Governance
Gilead Sciences, Inc.: Financial Deals
Gilead Sciences, Inc.: Financial Performance
Gilead Sciences, Inc.: Red Flags/DistressSignals
Gilead Sciences, Inc.: Regulatory and Legal Events
Gilead Sciences, Inc.: Research & Development
Appendix
Contact Us
Methodology
Definitions
About Datamonitor

List of Tables

Table 1: Gilead Sciences, Inc.: Key Facts
Table 2: Gilead Sciences, Inc.: Key Employees
Table 4: Gilead Sciences, Inc.: Key Competitors
Table 5: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Gilead Sciences, Inc.: M&A Activity by Geography (TTM*)
Table 7: Gilead Sciences, Inc.: Deal Activity by Deal Type - Volume (2009 - YTD*2013)
Table 8: Gilead Sciences, Inc.: M&A Average Deal Size - Value (US$m)
Table 9: Gilead Sciences, Inc.: Targets and Partners
Table 10: Gilead Sciences, Inc.: Top Deals 2009 - 2013YTD*
Table 11: Gilead Sciences, Inc.: Legal Advisor Ranking by Value (US$m)
Table 12: Gilead Sciences, Inc.: Financial Advisor Ranking by Value (US$m)
Table 13: Gilead Sciences, Inc.: M&A Volume and Value Trend (2009 - YTD*2013)
Table 14: Gilead Sciences, Inc.: M&A Activity by Geography (2009 - YTD*2013)
Table 15: Gilead Sciences, Inc.: Capital Raising Volume and Value Trend (2009 - YTD*2013)
Table 16: Gilead Sciences, Inc.: Capital Raising by Deal Type (2009 - YTD*2013)
Table 17: Gilead Sciences, Inc.: Partnership Volume and Value Trend (2009 - YTD*2013)
Table 18: Gilead Sciences, Inc.: Partnership Trend by Deal Type (2009 - YTD*2013)
Table 19: Gilead Sciences, Inc.: Private Equity and Ownership Volume and Value Trend (2009 - YTD*2013)
Table 20: Gilead Sciences, Inc.: Private Equity and Ownership Volume by Deal Type (2009 - YTD*2013)

Full Table of Contents is available at:
-- www.fastmr.com/catalog/product.aspx?productid=736893&dt=t

About MarketLine

MarketLine is a global publisher of company, industry and country information. Their clients operate across a wide variety of industries and job functions and range from multinational corporations right down to small businesses in both developed and developing economies. MarketLine users enjoy access to content that is trustworthy, up to date and reasonably priced and routinely turn to them as their first-stop resource for instantly accessible, reliable business information. View more research from MarketLine at www.fastmr.com/catalog/publishers.aspx?pubid=1034

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com